CHE vs PACS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 03, 2026
CHE
PACS
Investment Advisor Scores
PACS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CHE | PACS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 22.1239 | 20.5339 | PACS |
| PEG Ratio | 2.2132 | 1.3678 | PACS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.8% | 11.2% | PACS |
| Earnings Growth | 43.7% | 194.1% | PACS |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.0/100 | 54.3/100 | PACS |
| Profit Margin | 10.6% | 4.5% | CHE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CHE
MarkupPrice above SMA50, rising 50-day trend (7.6% over 20 days), RSI 75
PACS
MarkupPrice above SMA50, rising 50-day trend (10.7% over 20 days), RSI 52
Fundamentals Snapshot
| Metric | CHE | PACS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 19.6 | 18.2 |
| Trailing P/E | 26.7 | 29.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.1% |
| Gross Margin | 0.3% | 0.2% |
| Operating Margin | 0.1% | 0.1% |
| EPS | 19.91 | 1.55 |
| Dividend Yield | 0.00% | — |